Skip to main content

Table 5 Comparison of PsA patient subsets by univariable analyses

From: Characterization of bone metabolism in hungarian psoriatic arthritis patients: a case–control study

Dependent variable

Independent variable

Univariate analysis

B (95% CI)

β

p value

Femoral neck areal BMD

Age

−0.003 (− 0.005 - -0.001)

−0.307

0.001

Psoriasis duration

−0.002 (− 0.005–0.000)

− 0.211

< 0.001

Body Mass Index

0.004 (0.000–0.009)

0.180

0.050

Arthritis duration

−0.005 (− 0.008 – − 0.002)

−0.286

0.002

L1-L4 areal BMD

Sex (women vs. men)

−0.068 (− 0.139 - -0.001)

−1.174

0.049

Distal radius total volumetric BMD

Age

−1.563 (−2.397 - -0.729)

−0.326

< 0.001

Menopause duration

−2.213 (−4.070 - -0.356)

− 0.352

0.021

Distal radius trabecular volumetric BMD

Age

−0.836 (−1.491 - -0.181)

− 0.228

0.031

Sex (women vs. men)

−24.338 (−41.172 - -7.505)

− 0.257

0.005

Fertility duration

2482 (0.124–4.480)

0.315

0.040

Distal radius cortical volumetric BMD

Age

−2.116 (−3.376 - -0.857)

−0.295

0.001

10 year probability of major osteoporotic fracture

DAS28

1.351 (0.379–2.323)

0.277

0.007

Psoriasis duration

0.085 (0.001–0.170)

0.198

0.048

Arthritis duration

0.165 (0.045–0.286)

0.265

0.008

Menopause duration

0.348 (0.142–0.554)

0.470

0.001

cDMARD vs bDMARD

−2.890 (−5.049 - -0.731)

−0.259

0.009

10 year probability of hip fracture

Psoriasis duration

0.054 (0.008–0.100)

0.230

0.021

Arthritis duration

0.080 (0.013–0.146)

0.233

0.020

Menopause duration

0.178 (0.051–0.305)

0.405

0.007

cDMARD vs bDMARD

−1.664 (−2.841 - -0.487)

−0.273

0.006

< 75 nmol/L vs ≥75 nmol/L 25OHD

−1.800 (−3.317 - -0.284)

− 0.232

0.020

< 50 nmol/L vs ≥50 nmol/L 25OHD

− 1.405 (− 2.598 - -0.213)

−0.230

0.021

  1. BMD Bone mineral density, DAS28 Disease activity Score in 28 joints, cDMARD Conventional disease-modifying anti-rheumatic drugs, bDMARD Biologic disease-modifying anti-rheumatic drugs, 25OHD 25-hydroxyvitamin D